Get Your Personalised Treatment Plan in Just 24 Hours.

Share your details to receive a personalised treatment plan, estimated costs, hospital recommendations, and expert guidance, “completely free.”

Your information is protected with HIPAA-compliant security standards. We only share your details with hospitals after your consent.

Cholangiocarcinoma is a rare and aggressive cancer that begins in the bile ducts. These thin tubes carry bile—a digestive fluid—from the liver and gallbladder to the small intestine. Cholangiocarcinoma can grow in various parts of the bile ducts and is categorized into three main types depending on its location:

Intrahepatic Cholangiocarcinoma: Found within the bile ducts inside the liver]
Perihilar (Hilar) Cholangiocarcinoma: Occurs in the bile ducts just outside the liver
Distal Cholangiocarcinoma: Located in the portion of the bile duct closest to the small intestine.

Treatment for cholangiocarcinoma aims to eliminate or manage bile duct cancer, alleviate bile flow obstruction, regulate symptoms, and increase survival. The malignancy can spread quickly if treatment is not received, leading to systemic problems, liver damage, and jaundice.

Consult a physician if you have persistent jaundice (yellowing of the skin and eyes), black urine, pale stools, abdominal pain, itching, or unexplained weight loss. Early discovery greatly enhances treatment results, and MediGence's skilled network of specialised physicians makes it simple to obtain professional care for prompt diagnosis and individualised care.

Imaging studies like MRIs, MRCPs, CT scans, and PET scans are part of the preparation process to determine the tumour's location and size. Blood tests are conducted, including liver function and tumour indicators such as CA 19-9. A biopsy or endoscopic procedure (ERCP or EUS) might be necessary.

Surgical Resection: A section of the liver, bile duct, or surrounding tissue is surgically excised if the cancer is confined. A liver transplant is taken into consideration in certain situations.
Biliary Drainage: To treat jaundice and enhance liver function, stents may be inserted during ERCP for obstructed bile ducts.
Chemotherapy & Radiation: Radiation and chemotherapy can be used as a main treatment in the absence of surgery, or before or after surgery. In more advanced situations, immunotherapy or targeted therapy may be recommended.

The average length of surgery is 4–8 hours, and the duration of hospitalization is 1-2 weeks. It could take several months to recover. Radiation or chemotherapy is administered in weeks or months.

Structural irregularities at the junction of your pancreatic and bile ducts.
Choledochal cyst disease (bile duct cysts) or bile duct stones.
Clonorchiasis (Chinese liver fluke parasite infection)
Chronic ulcerative colitis
Liver Cirrhosis
Hepatitis C or B
Human immunodeficiency virus
IBD, or inflammatory bowel disease
Steatotic liver disease, linked to metabolic abnormalities.
Primary sclerosing cholangitis

A successful course of treatment can considerably prolong life, alleviate symptoms including itching and jaundice, repair liver function, and enhance general quality of life. Early intervention offers the best chance for long-term survival.

Monitoring liver function, providing nutritional assistance, and caring for wounds are all part of recovery. Patients may require biliary stents, either permanent or temporary. Follow-up treatment is crucial and involves routine lab and imaging testing to monitor for any indications of problems or recurrence.

Bile duct cancer treatment results improve due to early detection and cutting-edge medical treatments. Even while survival rates are higher in detected early instances, continuous advancements are improving success at every stage in personalised treatment.